Philipp Taussky
Overview
Explore the profile of Philipp Taussky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
168
Citations
865
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Alwakaa O, Enriquez-Marulanda A, Ramirez-Velandia F, Filo J, Mensah E, Wadhwa A, et al.
World Neurosurg
. 2024 Sep;
191:e697-e706.
PMID: 39265938
Background: The Matsushima grade has traditionally been used to evaluate vessel ingrowth from the superficial temporal artery after encephalo-duro-arterio-synangiosis (EDAS) for Moyamoya disease (MMD) patients. However, this grading is subjective...
12.
Wadhwa A, Ramirez-Velandia F, Mensah E, Salih M, Enriquez-Marulanda A, Young M, et al.
Neurosurg Rev
. 2024 Aug;
47(1):483.
PMID: 39190045
Dual antiplatelet therapy (DAPT) use is the standard of practice after flow diversion (FD) for intracranial aneurysms (IAs). Yet, no consensus exists in the literature regarding the optimal regimen. Certain...
13.
Ramirez-Velandia F, Filo J, Enriquez-Marulanda A, Fodor T, Sconzo D, Young M, et al.
J Neurosurg
. 2024 Aug;
142(1):78-87.
PMID: 39151194
Objective: Thromboembolic (TE) events are among the most feared complications after flow diversion (FD) and have been reported to occur even with adequate dual antiplatelet therapy. Herein, the authors characterize...
14.
McNeil E, Enriquez-Marulanda A, Ramirez Velandia F, Mackel C, Taussky P, Ogilvy C, et al.
World Neurosurg
. 2024 Aug;
190:e774-e780.
PMID: 39127374
Background And Objective: Surgery is the mainstay of stroke prevention in patients with symptomatic moyamoya disease (MMD). We present the results of a single-center retrospective study of indirect revascularization surgery...
15.
Barhouse P, Young M, Taussky P, Pacheco-Barrios N, Ogilvy C
J Neurosurg
. 2024 Aug;
142(1):127-137.
PMID: 39126718
Objective: Anterior choroidal artery (AChA) aneurysms account for 2%-5% of all intracranial aneurysms. Treatment considerations include microsurgical clipping, flow diversion, or coiling with or without adjunctive devices. AChA aneurysms pose...
16.
Ramirez-Velandia F, Enriquez-Marulanda A, Filo J, Fodor T, Sconzo D, Mensah E, et al.
World Neurosurg
. 2024 Aug;
190:e579-e587.
PMID: 39094933
Background: Factors impacting the rate of aneurysm occlusion after flow diversion (FD) have been well described in the literature. In this article, we sought to evaluate those variables to develop...
17.
Enriquez-Marulanda A, Ramirez-Velandia F, Young M, Stout J, See A, Ogilvy C, et al.
J Neurosurg
. 2024 Aug;
142(1):40-51.
PMID: 39094198
Cerebral bypass surgery is one of the most complex and elegant procedures in neurosurgery. It involves several meticulous steps that test the skills of even the most prepared neurosurgeons. This...
18.
Gelman J, Filo J, Ramirez-Velandia F, Enriquez-Marulanda A, Blitz S, Muram S, et al.
World Neurosurg
. 2024 Jul;
190:e394-e402.
PMID: 39067693
Background: As endovascular neurosurgery techniques continue to evolve, medical students in the United States have widely varying exposures to the field, particularly with respect to opportunities for hands-on experiences. Current...
19.
Ramirez-Velandia F, Wadhwa A, Mensah E, Sathya A, Pacheco-Barrios N, Filo J, et al.
World Neurosurg
. 2024 Jul;
190:422-433.e3.
PMID: 39067688
Background: Endovascular options for the treatment of basilar apex aneurysms (BAAs) are heterogeneous, and evidence is limited to retrospective cohorts and case series. We seek to evaluate the efficacy and...
20.
Dmytriw A, Salim H, Musmar B, Cancelliere N, Griessenauer C, Regenhardt R, et al.
Clin Neuroradiol
. 2024 Jul;
34(4):907-917.
PMID: 39023541
Background: The comparative efficacy and safety of first-generation flow diverters (FDs), Pipeline Embolization Device (PED) (Medtronic, Irvine, California), Silk (Balt Extrusion, Montmorency, France), Flow Re-direction Endoluminal Device (FRED) (Microvention, Tustin,...